We’re planning a public offering!

This is your chance to own a stake in the one company that may have solved a pervasive and potentially deadly disease: obstructive sleep apnea.

Don’t miss out!

INDICATE YOUR INTEREST TODAY
A REVOLUTIONARY SOLUTION
REGULATION A+

The Vivos Initial Public Offering

Own a stake in the one company that may have solved a pervasive and potentially deadly disease.

Mild-to-moderate sleep apnea, snoring and Sleep Disordered Breathing affect millions of people around the world. Vivos has developed, and has been awarded patents, for a proprietary treatment protocol for the underlying cause of obstructive sleep apnea.

The Vivos System, includes a sophisticated clinical diagnostic protocol combined with a patented medical device. Professional healthcare providers, including doctors and specially trained dentists design and manage a complete treatment protocol to assist patients suffering from a variety of conditions brought on by underdeveloped upper and lower jaws.

By harnessing dormant genetic potential, The Vivos System, may be the first permanent, non-surgical solution for individuals of all ages who are unable to breathe properly during sleep. The Vivos System offers non-invasive, structural craniofacial corrections.

Recent research has revealed possible links between impaired breathing during sleep with many of the most pervasive and potentially serious diseases.

OBVIOUS WARNING SIGNS

Chronic Snoring

LOUD + PERSISTENT

Gasping Episodes

GASPING DURING SLEEP

Daytime Drowsiness

FREQUENTLY TIRED

Headaches

MORNING

NOT SO OBVIOUS WARNING SIGNS

Chronic Pain

PERSISTENT

Obesity

OVERWEIGHT

Hypertension

HIGH BLOOD PRESSURE

Mood Swings

DEPRESSION + ANXIETY

Many common illnesses may be the result of impaired breathing during sleep.

At Vivos Therapeutics, we exist to provide hope and healing for millions of men, women and children who live with the devastating effects of impaired breathing while sleeping.

Please indicate your investment interest by filling out the form below.

No money is due today.

Interest Level:*

IT MIGHT NOT BE AS FUNNY AS IT SEEMS
OTHER CONDITIONS POSSIBLY CONNECTED TO SLEEP APNEA
  • Hypertension

  • Diabetes

  • Asthma

  • Chronic Allergies

  • Headaches

  • Anxiety

  • Depression

  • Daytime Drowsiness

  • Hypothyroidism

  • Snoring

  • Obesity

  • Fibromyalgia

  • Attention Deficit

  • Aggression

  • Chronic Pain

Vivos has assembled a world-class science and research team, an experienced and seasoned executive management team, and a global network of integrated practices to create real equity and value for our shareholders, employees, partners and patients.

An investment in Vivos, is an investment in a company working to solve a not-so silent, but potentially deadly healthcare crisis.

THE PROBLEM

A Compromised Airway

One of the leading causes of obstructive sleep apnea is a narrow, compromised airway.

THE SOLUTION

The Vivos Treatment Protocol & Patented Medical Devices

The Vivos System includes an advanced diagnostic protocol developed by a team of research scientists and practitioners aimed at identifying craniofacial abnormalities combined with The Vivos Appliance System.

Vivos works with practitioners to transform their practice to ensure our revolutionary treatment is available world-wide. Our unique practice integration system ensures practitioners obtain specific clinical and diagnostic knowledge combined with advanced trining and operational support to ensure every new patient receives the highest-level of care to achieve an optimal outcome.

If you are interested in joining us in the fight, indicate you interest today.

VIVOS THERAPEUTICS, INC. (THE “COMPANY”) IS “TESTING THE WATERS” UNDER REGULATION A UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS PROCESS ALLOWS COMPANIES TO DETERMINE WHETHER THERE MAY BE INTEREST IN AN EVENTUAL OFFERING OF ITS SECURITIES. THE COMPANY IS NOT UNDER ANY OBLIGATION TO MAKE AN OFFERING UNDER REGULATION A. IT MAY CHOOSE TO MAKE AN OFFERING TO SOME, BUT NOT ALL, OF THE PEOPLE WHO INDICATE AN INTEREST IN INVESTING, AND THAT OFFERING MIGHT NOT BE MADE UNDER REGULATION A. IF THE COMPANY DOES GO AHEAD WITH AN OFFERING, IT WILL ONLY BE ABLE TO MAKE SALES AFTER IT HAS FILED AN OFFERING STATEMENT WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) AND THE SEC HAS “QUALIFIED” THE OFFERING STATEMENT. THE INFORMATION IN THAT OFFERING STATEMENT WILL BE MORE COMPLETE THAN THE INFORMATION THE COMPANY IS PROVIDING NOW, AND COULD DIFFER IN IMPORTANT WAYS. YOU MUST READ THE DOCUMENTS FILED WITH THE SEC BEFORE INVESTING. NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED FOR OUR REGULATION A+ OFFERING AT THIS TIME AND IF SENT IN TO VIVOS WILL NOT BE ACCEPTED. NO OFFER TO BUY SECURITIES IN A REGULATION A+ OFFERING OF VIVOS CAN BE ACCEPTED UNTIL VIVOS OFFERING STATEMENT IS QUALIFIED. ANY SUCH OFFER TO BUY SECURITIES MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ITS ACCEPTANCE IS GIVEN AFTER THE QUALIFICATION DATE. ANY INDICATIONS OF VIVOS OFFERING INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND.